Iqvia Holdings (IQV) EBIT (2012 - 2026)
Iqvia Holdings' (IQV) quarterly EBIT came in at $506.0 million in Q2 2026, little changed year-over-year from $506.0 million in Q2 2025, and down 1.56% quarter-over-quarter from $514.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) EBIT (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed EBIT across 15 years of filings, most recently posting $506.0 million for Q2 2026.
- In Q2 2026, EBIT changed 0.0% year-over-year to $506.0 million; the TTM figure through Jun 2026 stood at $2.2 billion (up 1.01% YoY), while the FY2025 annual figure was $2.2 billion, down 0.91% from the prior year.
- EBIT came in at $506.0 million for Q2 2026 at Iqvia Holdings, down from $514.0 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $627.0 million in Q4 2025 to a low of $379.0 million in Q4 2022.
- Average EBIT over 5 years is $510.0 million, with a median of $506.0 million recorded in 2024.
- The largest YoY upside for EBIT was 58.39% in 2022 against a maximum downside of 18.14% in 2022.
- Over 5 years, EBIT stood at $379.0 million in 2022, then soared by 32.19% to $501.0 million in 2023, then climbed by 24.95% to $626.0 million in 2024, then rose by 0.16% to $627.0 million in 2025, then dropped by 19.3% to $506.0 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were $506.0 million in Q2 2026, $514.0 million in Q1 2026, and $627.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 146.82 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 137.83 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 119.89 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -409,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -6.00 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 506.00 Mn |
| Mar 31, 2026 | 514.00 Mn |
| Dec 31, 2025 | 627.00 Mn |
| Sep 30, 2025 | 553.00 Mn |
| Jun 30, 2025 | 506.00 Mn |
| Mar 31, 2025 | 496.00 Mn |
| Dec 31, 2024 | 626.00 Mn |
| Sep 30, 2024 | 550.00 Mn |
| Jun 30, 2024 | 520.00 Mn |
| Mar 31, 2024 | 506.00 Mn |
| Dec 31, 2023 | 501.00 Mn |
| Sep 30, 2023 | 481.00 Mn |
| Jun 30, 2023 | 524.00 Mn |
| Mar 31, 2023 | 471.00 Mn |
| Dec 31, 2022 | 379.00 Mn |
| Sep 30, 2022 | 472.00 Mn |
| Jun 30, 2022 | 453.00 Mn |
| Mar 31, 2022 | 495.00 Mn |
| Dec 31, 2021 | 463.00 Mn |
| Sep 30, 2021 | 302.00 Mn |